Compare Edwards Lifesciences Corporation Common Stock (EW) vs Gitlab Inc (GTLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Gitlab Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Gitlab Inc trades at $53.51 (market cap $8.66B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 5.7× Gitlab Inc's market cap, and Gitlab Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | GTLB | |
|---|---|---|
Market Cap | $49.44B | $8.66B |
Volume | 3,508,027 | 2,403,535 |
Sector | Health | Technology |
52-Week High | $95.18 | $53.56 |
52-Week Low | $72.65 | $19.42 |
Enterprise Value | $45.90B | $7.40B |
Typical Hold Time | — | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GitLab (GTLB) trades at $53.56, up 3.74% today and near its 52-week high, with strong technical momentum. The company shows accelerating revenue growth (21.3% YoY in Q2 2026) and consistent earnings beats, though profitability remains negative. Recent AI product traction and raised guidance have fueled investor optimism, with the stock gaining 35% in August 2026 alone.
Outlook is mixed: strong sales momentum and AI integration offer upside, but high valuation (P/E 521) and negative margins pose risks. Analyst consensus is cautious (36.7% Buy, 60% Hold) with a $49.71 price target below current levels, suggesting limited near-term upside despite positive business trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →
